| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |